The coexistence of hypertension and dyslipidemia contributes to an increased risk of CVD, warranting efficient management strategies.
[ Dr Magno leads the first topic on evidence-based management of hypertension ]
Cardiovascular diseases (CVD) are the leading cause of death globally, with hypertension and dyslipidemia as major modifiable risk factors. The coexistence of hypertension and dyslipidemia contributes to an increased risk of CVD, warranting efficient management strategies.1
On February 27, 2025, at the 30th joint convention of the Philippine Society of Hypertension and Philippine Lipid and Atherosclerosis Society, Servier Philippines hosted a lunch symposium led by Dr Jose Donato Magno and Dr Ma. Cecille Cruz. They presented current evidence and evolving approaches in managing clinical scenarios in patients with both hypertension and dyslipidemia.